Anemia, Refractory, with Excess of Blasts
12 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
Anemia, Refractory, with Excess of Blasts| Treatment and condition | Where it stands | Trials |
|---|
| Cyclophosphamide for anemia, refractory, with excess of blasts | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Granulocyte Colony-Stimulating Factor (G-CSF) + MGTA 456 Infusion + Busulfan + FLUDARABINE + Melphalan + Mycophenolate Mofetil Hydrochloride for anemia, refractory, with excess of blasts | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Granulocyte Colony-Stimulating Factor (G-CSF) + MGTA 456 Infusion + Total Body Irradiation (TBI) + Cyclophosphamide + FLUDARABINE + Mycophenolate Mofetil Hydrochloride + Tacrolimus for anemia, refractory, with excess of blasts | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Mobilized CD34-selected Peripheral Blood Stem Cell graft for anemia, refractory, with excess of blasts | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for anemia, refractory, with excess of blasts | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Phase 2 Established Dose from prior study, NCT03810196 for anemia, refractory, with excess of blasts | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Phase 2 Maximum Tolerated Dose determined in Phase 1 for anemia, refractory, with excess of blasts | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Proton Total Marrow Irradiation for anemia, refractory, with excess of blasts | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Romiplostim for anemia, refractory, with excess of blasts | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Total-Body Irradiation + Umbilical Cord Blood Transplantation + Cyclophosphamide + DILANUBICEL + FLUDARABINE for anemia, refractory, with excess of blasts | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Total-Body Irradiation + Umbilical Cord Blood Transplantation + Cyclophosphamide + THIOTEPA + DILANUBICEL + FLUDARABINE for anemia, refractory, with excess of blasts | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Unmanipulated Bone Marrow Graft with Cyclophosphamide + Cyclophosphamide for anemia, refractory, with excess of blasts | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|